Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
45 Body composition as a predictive and prognostic biomarker in advanced urothelial carcinoma (UC) patients treated with immune checkpoint inhibitors (ICI)
Compose a Response to This Article
Other responses
No responses have been published for this article.
